NCT02622581 - Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients | Biotech Hunter

Enrollment

12,400

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2027

Conditions

Metastatic Non-small Cell Lung Cancer (NSCLC)Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IINon Small Cell Lung Cancer Stage IIISmall-cell Lung CancerNon-small Cell Lung Cancer Stage I

Interventions

OTHER

data collection

Baseline (demographic, clinical, tumor) characteristics, details on biomarker testing, including re-testing, treatment decision making, all systemic anticancer therapies including details, key data on radiotherapies, surgeries and specified supportive therapies, outcome (response, progression, survival), course of disease. Data will be documented at baseline and updated at least every three months.

Trial Locations (1)

26121

RECRUITING

Pius-Hospital, Oldenburg